{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:28:56Z","timestamp":1792153736375,"version":"4.4.0"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T00:00:00Z","timestamp":1592697600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Pediatric Neurology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.spen.2020.100829","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T12:26:56Z","timestamp":1592915216000},"page":"100829","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":128,"special_numbering":"C","title":["Mitochondrial Dysfunction in Autism Spectrum Disorder: Unique Abnormalities and Targeted Treatments"],"prefix":"10.1016","volume":"35","author":[{"given":"Richard E.","family":"Frye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.spen.2020.100829_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6513a1","article-title":"Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2012","volume":"65","author":"Christensen","year":"2018","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.spen.2020.100829_bib0002","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s40263-018-0556-y","article-title":"Social Skills Deficits in Autism Spectrum Disorder: Potential Biological Origins and Progress in Developing Therapeutic Agents","volume":"32","author":"Frye","year":"2018","journal-title":"CNS Drugs"},{"key":"10.1016\/j.spen.2020.100829_bib0003","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/mp.2011.165","article-title":"A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures","volume":"17","author":"Rossignol","year":"2012","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.spen.2020.100829_bib0004","doi-asserted-by":"crossref","first-page":"792","DOI":"10.21037\/atm.2019.11.53","article-title":"Emerging biomarkers in autism spectrum disorder: a systematic review","volume":"7","author":"Frye","year":"2019","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.spen.2020.100829_bib0005","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fphys.2014.00150","article-title":"Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism","volume":"5","author":"Rossignol","year":"2014","journal-title":"Front Physiol"},{"key":"10.1016\/j.spen.2020.100829_bib0006","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1001\/jama.2015.10078","article-title":"Molecular Diagnostic Yield of Chromosomal Microarray Analysis and Whole-Exome Sequencing in Children With Autism Spectrum Disorder","volume":"314","author":"Tammimies","year":"2015","journal-title":"Jama"},{"key":"10.1016\/j.spen.2020.100829_bib0007","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nm.3792","article-title":"Whole-genome sequencing of quartet families with autism spectrum disorder","volume":"21","author":"Yuen","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.spen.2020.100829_bib0008","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ajhg.2017.09.008","article-title":"High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies","volume":"101","author":"Hamdan","year":"2017","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.spen.2020.100829_bib0009","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature10945","article-title":"De novo mutations revealed by whole-exome sequencing are strongly associated with autism","volume":"485","author":"Sanders","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.spen.2020.100829_bib0010","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/archgenpsychiatry.2011.76","article-title":"Genetic heritability and shared environmental factors among twin pairs with autism","volume":"68","author":"Hallmayer","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.spen.2020.100829_bib0011","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/mp.2010.136","article-title":"Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis","volume":"17","author":"Rossignol","year":"2012","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.spen.2020.100829_bib0012","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s40291-018-0352-x","article-title":"Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder","volume":"22","author":"Rose","year":"2018","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.spen.2020.100829_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01837894","article-title":"Autism and lactic acidosis","volume":"15","author":"Coleman","year":"1985","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.spen.2020.100829_bib0014","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1469-8749.2007.00726.x","article-title":"Epidemiology of autism spectrum disorder in Portugal: prevalence, clinical characterization, and medical conditions","volume":"49","author":"Oliveira","year":"2007","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.spen.2020.100829_bib0015","doi-asserted-by":"crossref","first-page":"e3815","DOI":"10.1371\/journal.pone.0003815","article-title":"Mitochondrial disease in autism spectrum disorder patients: a cohort analysis","volume":"3","author":"Weissman","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.spen.2020.100829_bib0016","doi-asserted-by":"crossref","first-page":"41R","DOI":"10.1203\/PDR.0b013e318212f16b","article-title":"Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders","volume":"69","author":"Frye","year":"2011","journal-title":"Pediatr Res"},{"key":"10.1016\/j.spen.2020.100829_bib0017","series-title":"Mitochondrial dysfunction in autism spectrum disorder","author":"Frye","year":"2019"},{"key":"10.1016\/j.spen.2020.100829_bib0018","doi-asserted-by":"crossref","first-page":"141","DOI":"10.7156\/v5i3p141","article-title":"Biomarkers of Abnormal Energy Metabolism in Children with Autism Spectrum Disorder","volume":"5","author":"Frye","year":"2012","journal-title":"N A J Med Sci"},{"key":"10.1016\/j.spen.2020.100829_bib0019","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1001\/jama.2010.1706","article-title":"Mitochondrial dysfunction in autism","volume":"304","author":"Giulivi","year":"2010","journal-title":"Jama"},{"key":"10.1016\/j.spen.2020.100829_bib0020","doi-asserted-by":"crossref","first-page":"e1405","DOI":"10.1542\/peds.2013-1545","article-title":"Deficits in bioenergetics and impaired immune response in granulocytes from children with autism","volume":"133","author":"Napoli","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.spen.2020.100829_bib0021","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2217\/bmm.15.72","article-title":"Mitochondrial enzyme dysfunction in autism spectrum disorders; a novel biomarker revealed from buccal swab analysis","volume":"9","author":"Goldenthal","year":"2015","journal-title":"Biomark Med"},{"key":"10.1016\/j.spen.2020.100829_bib0022","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1007\/s11011-017-0087-0","article-title":"Bioenergetic variation is related to autism symptomatology","volume":"32","author":"Delhey","year":"2017","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.spen.2020.100829_bib0023","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/088307380001500601","article-title":"Autism associated with the mitochondrial DNA G8363A transfer RNA(Lys) mutation","volume":"15","author":"Graf","year":"2000","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2020.100829_bib0024","first-page":"427","article-title":"Autistic disorder with complex IV overactivity: A new mitochondrial syndrome","volume":"9","author":"Frye","year":"2011","journal-title":"Journal of Pediatric Neurology"},{"key":"10.1016\/j.spen.2020.100829_bib0025","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/mp.2008.63","article-title":"Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate\/glutamate carrier AGC1","volume":"15","author":"Palmieri","year":"2010","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.spen.2020.100829_bib0026","article-title":"Alterations in mitocohndrial respiratiory capacity and membrane potential: a link between mitochondrial dysregulation and autism","author":"Hassan","year":"2020","journal-title":"MitoFit"},{"key":"10.1016\/j.spen.2020.100829_bib0027","doi-asserted-by":"crossref","first-page":"e85436","DOI":"10.1371\/journal.pone.0085436","article-title":"Oxidative stress induces mitochondrial dysfunction in a subset of autism lymphoblastoid cell lines in a well-matched case control cohort","volume":"9","author":"Rose","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.spen.2020.100829_bib0028","doi-asserted-by":"crossref","first-page":"e377","DOI":"10.1038\/tp.2014.15","article-title":"Oxidative stress induces mitochondrial dysfunction in a subset of autistic lymphoblastoid cell lines","volume":"4","author":"Rose","year":"2014","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.spen.2020.100829_bib0029","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1096\/fj.201601004R","article-title":"Mitochondrial and redox abnormalities in autism lymphoblastoid cells: a sibling control study","volume":"31","author":"Rose","year":"2017","journal-title":"FASEB J"},{"key":"10.1016\/j.spen.2020.100829_bib0030","doi-asserted-by":"crossref","unstructured":"Bennuri, S.C., Rose, S. & Frye, R.E.Mitochondrial dysfunction is inducible in lymphoblastoid cell lines from children with autism and may involve the TORC1 pathway Frontiers in Psychiatry: Molecular Psychiatry. 10: 269:261-213; 2019.","DOI":"10.3389\/fpsyt.2019.00269"},{"key":"10.1016\/j.spen.2020.100829_bib0031","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.1038\/s41598-017-04821-3","article-title":"Oxidative Stress Challenge Uncovers Trichloroacetaldehyde Hydrate-Induced Mitoplasticity in Autistic and Control Lymphoblastoid Cell Lines","volume":"7","author":"Frye","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.spen.2020.100829_bib0032","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/573701","article-title":"Increased susceptibility to ethylmercury-induced mitochondrial dysfunction in a subset of autism lymphoblastoid cell lines","volume":"2015","author":"Rose","year":"2015","journal-title":"J Toxicol"},{"key":"10.1016\/j.spen.2020.100829_bib0033","doi-asserted-by":"crossref","first-page":"e927","DOI":"10.1038\/tp.2016.189","article-title":"Modulation of mitochondrial function by the microbiome metabolite propionic acid in autism and control cell lines","volume":"6","author":"Frye","year":"2016","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.spen.2020.100829_bib0034","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41398-017-0089-z","article-title":"Butyrate enhances mitochondrial function during oxidative stress in cell lines from boys with autism","volume":"8","author":"Rose","year":"2018","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.spen.2020.100829_bib0035","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/acn3.51034","article-title":"Developmental regression and mitochondrial function in children with autism","volume":"7","author":"Singh","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.spen.2020.100829_bib0036","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/archotol.128.4.355","article-title":"The otolaryngological manifestations of mitochondrial disease and the risk of neurodegeneration with infection","volume":"128","author":"Edmonds","year":"2002","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.spen.2020.100829_bib0037","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1177\/0883073809342128","article-title":"Fever plus mitochondrial disease could be risk factors for autistic regression","volume":"25","author":"Shoffner","year":"2010","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2020.100829_bib0038","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.rasd.2012.07.006","article-title":"l-Carnitine supplementation improves the behavioral symptoms in autistic children","volume":"7","author":"Fahmy","year":"2013","journal-title":"Research in Autism Spectrum Disorders"},{"key":"10.1016\/j.spen.2020.100829_bib0039","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.881792","article-title":"A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders","volume":"17","author":"Geier","year":"2011","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.spen.2020.100829_bib0040","article-title":"Side Effects and Behavioral Outcomes Following High-Dose Carnitine Supplementation Among Young Males With Autism Spectrum Disorder: A Pilot Study","volume":"6","author":"Goin-Kochel","year":"2019","journal-title":"Glob Pediatr Health"},{"key":"10.1016\/j.spen.2020.100829_bib0041","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1002\/ajmg.a.37144","article-title":"Improvement of regressive autism symptoms in a child with TMLHE deficiency following carnitine supplementation","volume":"167A","author":"Ziats","year":"2015","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.spen.2020.100829_bib0042","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3390\/brainsci9060137","article-title":"First Case Report of Primary Carnitine Deficiency Manifested as Intellectual Disability and Autism Spectrum Disorder","volume":"9","author":"Guevara-Campos","year":"2019","journal-title":"Brain Sci"},{"key":"10.1016\/j.spen.2020.100829_bib0043","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fpubh.2013.00031","article-title":"A review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a systematic review and expert panel","volume":"1","author":"Frye","year":"2013","journal-title":"Front Public Health"},{"key":"10.1016\/j.spen.2020.100829_bib0044","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/798957","article-title":"Ubiquinol improves symptoms in children with autism","volume":"2014","author":"Gvozdjakova","year":"2014","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.spen.2020.100829_bib0045","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.psychres.2018.03.061","article-title":"Coenzyme Q10 supplementation reduces oxidative stress and decreases antioxidant enzyme activity in children with autism spectrum disorders","volume":"265","author":"Mousavinejad","year":"2018","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.spen.2020.100829_bib0046","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4137\/AUI.S6947","article-title":"Biochemical Effects of Ribose and NADH Therapy in Children with Autism","volume":"3","author":"Adams","year":"2011","journal-title":"Autism Insights"},{"key":"10.1016\/j.spen.2020.100829_bib0047","first-page":"303","article-title":"Treatment of autism spectrum children with thiamine tetrahydrofurfuryl disulfide: a pilot study","volume":"23","author":"Lonsdale","year":"2002","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1016\/j.spen.2020.100829_bib0048","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.pediatrneurol.2017.10.013","article-title":"Biotin and Acetazolamide for Treatment of an Unusual Child With Autism Plus Lack of Nail and Hair Growth","volume":"79","author":"Benke","year":"2018","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2020.100829_bib0049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu10030369","article-title":"Comprehensive Nutritional and Dietary Intervention for Autism Spectrum Disorder-A Randomized, Controlled 12-Month Trial","volume":"10","author":"Adams","year":"2018","journal-title":"Nutrients"},{"issue":"111","key":"10.1016\/j.spen.2020.100829_bib0050","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1471-2431-11-111","article-title":"Effect of a vitamin\/mineral supplement on children and adults with autism","volume":"11","author":"Adams","year":"2011","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.spen.2020.100829_bib0051","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2217\/bmm.13.158","article-title":"Metabolic pathology of autism in relation to redox metabolism","volume":"8","author":"Frye","year":"2014","journal-title":"Biomark Med"},{"key":"10.1016\/j.spen.2020.100829_bib0052","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.neubiorev.2015.04.015","article-title":"Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review","volume":"55","author":"Deepmala","year":"2015","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.spen.2020.100829_bib0053","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2217\/bmm-2017-0109","article-title":"Folate metabolism abnormalities in autism: potential biomarkers","volume":"11","author":"Frye","year":"2017","journal-title":"Biomark Med"},{"key":"10.1016\/j.spen.2020.100829_bib0054","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000446586","article-title":"Primary Mitochondrial Disease and Secondary Mitochondrial Dysfunction: Importance of Distinction for Diagnosis and Treatment","volume":"7","author":"Niyazov","year":"2016","journal-title":"Mol Syndromol"},{"issue":"18","key":"10.1016\/j.spen.2020.100829_bib0055","first-page":"11","article-title":"The Effect of Mitochondrial Supplements on Mitochondrial Activity in Children with Autism Spectrum Disorder","volume":"6","author":"Delhey","year":"2017","journal-title":"J Clin Med"},{"key":"10.1016\/j.spen.2020.100829_bib0056","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.90.15_supplement.P3.313","article-title":"Effect of a Combination of Carnitine, Coenzyme Q10 and Alpha-Lipoic Acid (MitoCocktail) on Mitochondrial Function and Neurobehavioral Performance in Children with Autism Spectrum Disorder (P3.313)","volume":"90","author":"Legido","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2020.100829_bib0057","first-page":"113","article-title":"Prevalence, Significance and Clinical Characteristics of Seizures, Epilepsy and Subclinical Electrical Activity in Autism","volume":"8","author":"Frye","year":"2015","journal-title":"N A J Med Sci"},{"key":"10.1016\/j.spen.2020.100829_bib0058","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2431-11-37","article-title":"Traditional and non-traditional treatments for autism spectrum disorder with seizures: an on-line survey","volume":"11","author":"Frye","year":"2011","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.spen.2020.100829_bib0059","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/08830738030180020501","article-title":"Application of a ketogenic diet in children with autistic behavior: pilot study","volume":"18","author":"Evangeliou","year":"2003","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2020.100829_bib0060","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.physbeh.2018.02.006","article-title":"A modified ketogenic gluten-free diet with MCT improves behavior in children with autism spectrum disorder","volume":"188","author":"Lee","year":"2018","journal-title":"Physiol Behav"},{"key":"10.1016\/j.spen.2020.100829_bib0061","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1021\/acs.jproteome.9b00581","article-title":"Metabolic Framework for the Improvement of Autism Spectrum Disorders by a Modified Ketogenic Diet: A Pilot Study","volume":"19","author":"Mu","year":"2020","journal-title":"J Proteome Res"},{"key":"10.1016\/j.spen.2020.100829_bib0062","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s11011-017-0088-z","article-title":"Ketogenic diet versus gluten free casein free diet in autistic children: a case-control study","volume":"32","author":"El-Rashidy","year":"2017","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.spen.2020.100829_bib0063","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.physbeh.2016.10.023","article-title":"Ketogenic diets improve behaviors associated with autism spectrum disorder in a sex-specific manner in the EL mouse","volume":"168","author":"Ruskin","year":"2017","journal-title":"Physiol Behav"},{"key":"10.1016\/j.spen.2020.100829_bib0064","doi-asserted-by":"crossref","first-page":"e65021","DOI":"10.1371\/journal.pone.0065021","article-title":"Ketogenic diet improves core symptoms of autism in BTBR mice","volume":"8","author":"Ruskin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.spen.2020.100829_bib0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171643","article-title":"Ketogenic diet improves behaviors in a maternal immune activation model of autism spectrum disorder","volume":"12","author":"Ruskin","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.spen.2020.100829_bib0066","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/1028415X.2015.1133029","article-title":"The effect of ketogenic diet in an animal model of autism induced by prenatal exposure to valproic acid","volume":"20","author":"Castro","year":"2017","journal-title":"Nutr Neurosci"},{"key":"10.1016\/j.spen.2020.100829_bib0067","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s11011-018-0219-1","article-title":"Therapeutic use of carbohydrate-restricted diets in an autistic child; a case report of clinical and 18FDG PET findings","volume":"33","author":"Zarnowska","year":"2018","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.spen.2020.100829_bib0068","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fped.2014.00069","article-title":"Potential therapeutic use of the ketogenic diet in autism spectrum disorders","volume":"2","author":"Napoli","year":"2014","journal-title":"Front Pediatr"},{"key":"10.1016\/j.spen.2020.100829_bib0069","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000362645","article-title":"The ketogenic diet modifies social and metabolic alterations identified in the prenatal valproic acid model of autism spectrum disorder","volume":"36","author":"Ahn","year":"2014","journal-title":"Dev Neurosci"},{"issue":"3266","key":"10.1016\/j.spen.2020.100829_bib0070","article-title":"Aberrant Mitochondrial Morphology and Function in the BTBR Mouse Model of Autism Is Improved by Two Weeks of Ketogenic Diet","volume":"21","author":"Ahn","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.spen.2020.100829_bib0071","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3389\/fphys.2016.00654","article-title":"Tissue Specific Impacts of a Ketogenic Diet on Mitochondrial Dynamics in the BTBR(T+tf\/j) Mouse","volume":"7","author":"Newell","year":"2016","journal-title":"Front Physiol"},{"key":"10.1016\/j.spen.2020.100829_bib0072","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13229-016-0099-3","article-title":"Ketogenic diet modifies the gut microbiota in a murine model of autism spectrum disorder","volume":"7","author":"Newell","year":"2016","journal-title":"Mol Autism"},{"key":"10.1016\/j.spen.2020.100829_bib0073","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bbr.2016.02.015","article-title":"Ketogenic diet restores aberrant cortical motor maps and excitation-to-inhibition imbalance in the BTBR mouse model of autism spectrum disorder","volume":"304","author":"Smith","year":"2016","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.spen.2020.100829_bib0074","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/aur.1682","article-title":"Genetic modifications associated with ketogenic diet treatment in the BTBR(T+Tf\/J) mouse model of autism spectrum disorder","volume":"10","author":"Mychasiuk","year":"2017","journal-title":"Autism Res"},{"key":"10.1016\/j.spen.2020.100829_bib0075","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10545-016-0011-5","article-title":"Ketogenic diet in pyruvate dehydrogenase complex deficiency: short- and long-term outcomes","volume":"40","author":"Sofou","year":"2017","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.spen.2020.100829_bib0076","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1212\/WNL.49.6.1655","article-title":"Outcome of pyruvate dehydrogenase deficiency treated with ketogenic diets. Studies in patients with identical mutations","volume":"49","author":"Wexler","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2020.100829_bib0077","article-title":"Reversal of cardiac hypertrophy with a ketogenic diet in a child with mitochondrial disease and hypertrophic cardiomyopathy","author":"Deberles","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.spen.2020.100829_bib0078","first-page":"10","article-title":"Ketogenic diet for treating alopecia in BCS1l-related mitochondrial disease (Bjornstad syndrome)","volume":"53","author":"Della Marina","year":"2020","journal-title":"JIMD Rep"},{"key":"10.1016\/j.spen.2020.100829_bib0079","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.braindev.2008.12.020","article-title":"A case of Ohtahara syndrome with mitochondrial respiratory chain complex I deficiency","volume":"32","author":"Seo","year":"2010","journal-title":"Brain Dev"},{"key":"10.1016\/j.spen.2020.100829_bib0080","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.pediatrneurol.2006.01.012","article-title":"Landau-Kleffner syndrome with mitochondrial respiratory chain-complex I deficiency","volume":"35","author":"Kang","year":"2006","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2020.100829_bib0081","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1684\/epd.2012.0543","article-title":"Successful treatment of POLG-related mitochondrial epilepsy with antiepileptic drugs and low glycaemic index diet","volume":"14","author":"Martikainen","year":"2012","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.spen.2020.100829_bib0082","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.spen.2010.02.012","article-title":"Compound heterozygous polymerase gamma gene mutation in a patient with Alpers disease","volume":"17","author":"Cardenas","year":"2010","journal-title":"Semin Pediatr Neurol"},{"key":"10.1016\/j.spen.2020.100829_bib0083","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.pediatrneurol.2014.01.009","article-title":"Mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS) may respond to adjunctive ketogenic diet","volume":"50","author":"Steriade","year":"2014","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2020.100829_bib0084","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ymgme.2017.11.003","article-title":"The genotypic and phenotypic spectrum of MTO1 deficiency","volume":"123","author":"O'Byrne","year":"2018","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.spen.2020.100829_bib0085","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ymgme.2016.11.005","article-title":"Succinyl-CoA synthetase (SUCLA2) deficiency in two siblings with impaired activity of other mitochondrial oxidative enzymes in skeletal muscle without mitochondrial DNA depletion","volume":"120","author":"Huang","year":"2017","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.spen.2020.100829_bib0086","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.braindev.2018.02.004","article-title":"An infant case of diffuse cerebrospinal lesions and cardiomyopathy caused by a BOLA3 mutation","volume":"40","author":"Nishioka","year":"2018","journal-title":"Brain Dev"},{"key":"10.1016\/j.spen.2020.100829_bib0087","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.15252\/emmm.201606592","article-title":"Modified Atkins diet induces subacute selective ragged-red-fiber lysis in mitochondrial myopathy patients","volume":"8","author":"Ahola","year":"2016","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.spen.2020.100829_bib0088","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/hmg\/ddq076","article-title":"Ketogenic diet slows down mitochondrial myopathy progression in mice","volume":"19","author":"Ahola-Erkkila","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.spen.2020.100829_bib0089","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/s41598-017-01109-4","article-title":"Ketogenic diet attenuates hepatopathy in mouse model of respiratory chain complex III deficiency caused by a Bcs1l mutation","volume":"7","author":"Purhonen","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.spen.2020.100829_bib0090","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ymgme.2019.01.008","article-title":"Ketogenic and anaplerotic dietary modifications ameliorate seizure activity in Drosophila models of mitochondrial encephalomyopathy and glycolytic enzymopathy","volume":"126","author":"Fogle","year":"2019","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.spen.2020.100829_bib0091","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13023-019-1128-z","article-title":"Ketogenic treatment reduces the percentage of a LHON heteroplasmic mutation and increases mtDNA amount of a LHON homoplasmic mutation","volume":"14","author":"Emperador","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.spen.2020.100829_bib0092","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/ana.20240","article-title":"Ketogenic treatment reduces deleted mitochondrial DNAs in cultured human cells","volume":"56","author":"Santra","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.spen.2020.100829_bib0093","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1179\/1476830512Y.0000000003","article-title":"Effectiveness of the gluten-free, casein-free diet for children diagnosed with autism spectrum disorder: based on parental report","volume":"15","author":"Pennesi","year":"2012","journal-title":"Nutr Neurosci"},{"key":"10.1016\/j.spen.2020.100829_bib0094","doi-asserted-by":"crossref","first-page":"e220","DOI":"10.1038\/tp.2012.143","article-title":"Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder","volume":"3","author":"Frye","year":"2013","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.spen.2020.100829_bib0095","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1177\/0883073809361165","article-title":"5q14.3 deletion manifesting as mitochondrial disease and autism: case report","volume":"25","author":"Ezugha","year":"2010","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2020.100829_bib0096","doi-asserted-by":"crossref","first-page":"19544","DOI":"10.1038\/srep19544","article-title":"Mitochondrial Dysfunction may explain symptom variation in Phelan-McDermid Syndrome","volume":"6","author":"Frye","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.spen.2020.100829_bib0097","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.spen.2013.10.008","article-title":"Mitochondrial dysfunction in autism","volume":"20","author":"Legido","year":"2013","journal-title":"Semin Pediatr Neurol"},{"key":"10.1016\/j.spen.2020.100829_bib0098","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1212\/01.wnl.0000244435.27645.54","article-title":"Mitochondrial disease criteria: diagnostic applications in children","volume":"67","author":"Morava","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2020.100829_bib0099","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1177\/0883073809333531","article-title":"15q11.2-13 duplication, mitochondrial dysfunction, and developmental disorders","volume":"24","author":"Frye","year":"2009","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2020.100829_bib0100","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3389\/fped.2017.00219","article-title":"Autistic Siblings with Novel Mutations in Two Different Genes: Insight for Genetic Workups of Autistic Siblings and Connection to Mitochondrial Dysfunction","volume":"5","author":"Burger","year":"2017","journal-title":"Front Pediatr"}],"container-title":["Seminars in Pediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909120300401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909120300401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:37:09Z","timestamp":1761028629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071909120300401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":100,"alternative-id":["S1071909120300401"],"URL":"https:\/\/doi.org\/10.1016\/j.spen.2020.100829","relation":{},"ISSN":["1071-9091"],"issn-type":[{"value":"1071-9091","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondrial Dysfunction in Autism Spectrum Disorder: Unique Abnormalities and Targeted Treatments","name":"articletitle","label":"Article Title"},{"value":"Seminars in Pediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.spen.2020.100829","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100829"}}